INM
Closed
Inmed Pharmaceuticals Inc
3.09
-0.16 (-4.92%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 3.25
Day's Range: 3. - 3.165
Send
sign up or login to leave a comment!
When Written:
1.1
InMed Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that is focused on developing cannabinoid-based therapies for various diseases. The company's proprietary drug development platform, known as IntegraSyn, enables the identification and development of novel cannabinoid-based drug candidates. InMed's lead product candidate, INM-755, is currently in clinical trials for the treatment of epidermolysis bullosa, a rare genetic skin disorder. The company is also exploring the potential of its platform in the treatment of other diseases, including glaucoma, pain, and inflammation. InMed Pharmaceuticals is headquartered in Vancouver, Canada, and is listed on the Toronto Stock Exchange and the NASDAQ.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








